Evodiamine

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameEvodiamine
Drug Alias NameWu-Chu-Yu
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATPase inhibitorsPotassium channel antagonistsVoltage-gated calcium channel blockers
TargetsATPasePotassium channelVoltage-gated calcium channel
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Chemical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Chemical
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A